Norbert W. Bischofberger
Chief Executive Officer bei KRONOS BIO, INC.
Vermögen: 10 Mio $ am 31.03.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Praveen Tipirneni | M | 55 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 9 Jahre |
| Arie Belldegrun | M | 74 |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | 7 Jahre |
| Otello Stampacchia | M | 55 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 6 Jahre |
| Robert Farrell | M | 58 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 9 Jahre |
| Timothy Springer | M | 76 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 10 Jahre |
| Joshua Kazam | M | 47 |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | 7 Jahre |
| David Tanen | M | 52 |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | 7 Jahre |
| Marc Schegerin | M | 48 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 4 Jahre |
| William DeVaul | M | 53 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 5 Jahre |
| Nevan Krogan | M | - |
Rezo Therapeutics, Inc.
 Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | 2 Jahre |
| Roger Dansey | M | 68 | 3 Jahre | |
| Norbert Winkeljohann | M | 66 | 6 Jahre | |
| Gustav Christensen | M | 76 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 8 Jahre |
| Allison Frisbee | F | 41 | 4 Jahre | |
| Martin Edwards | M | 68 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 4 Jahre |
| Bruce Rogers | M | 55 | 8 Jahre | |
| Joseph Slattery | M | 59 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 5 Jahre |
| Susannah Gray | F | 63 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 3 Jahre |
| Amir Nashat | M | 51 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 7 Jahre |
| Nilesh Kumar | M | 47 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 6 Jahre |
| Vikas Goyal | M | 45 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 6 Jahre |
| Tai Yin Yang | M | 70 | 31 Jahre | |
| Nisha Nanda | M | 49 | 3 Jahre | |
| Arjun Goyal | M | - |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | 7 Jahre |
| Roshawn Blunt | F | 49 | 3 Jahre | |
| Nadir Mahmood | M | 44 |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | 1 Jahre |
| Katherine Stultz | F | 51 | 1 Jahre | |
| Jost Reinhard | M | - | 1 Jahre | |
| Kimberly Mathisen, MBA | - | - | 2 Jahre | |
| Brihad Abhyankar | M | - |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 2 Jahre |
| Blaise Lippa | M | - | 9 Jahre | |
| Sourav Bandyopadhyay | M | - |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | 2 Jahre |
| Stefan Vitorovic | M | 39 |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | 7 Jahre |
| Kelly Kramer | F | 56 | 8 Jahre | |
| Ertharin Cousin | M | 67 | 5 Jahre | |
| Elizabeth A. Olek | M | 59 | 2 Jahre | |
| Colleen Goggins | F | 68 | 7 Jahre | |
| Wolfgang U. Nickl | M | 55 | 6 Jahre | |
| Horst Heinz Paul Baier | M | 66 | 4 Jahre | |
| Fred Cohen | M | 67 |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | 7 Jahre |
| George Scangos | M | 76 |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | 2 Jahre |
| Andrew Dickinson | M | 54 | 8 Jahre | |
| Christine Cassiano | F | - |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | 7 Jahre |
| Alberto Weisser | M | 67 | 3 Jahre | |
| Jacqueline Barton | M | 71 | 6 Jahre | |
| Elena Ridloff | F | 44 | 4 Jahre | |
| Ulrich Von Adrian | M | - |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | - |
| Michael Westmeier | M | 51 | 2 Jahre | |
| Barbara Gansewendt | M | 60 | 2 Jahre | |
| Claudia Schade | F | 45 | 2 Jahre | |
| Sandra Gardiner | F | 58 | 1 Jahre | |
| Shea King | F | - |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | - |
| Charles Lin | M | 39 | 5 Jahre | |
| Andrea Sacher | F | 43 | 4 Jahre | |
| David Chang | M | 64 |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | - |
| Rajul Jain | M | - |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | - |
| Thomas Hoffmann | M | 53 | 5 Jahre | |
| Jean-Philippe Kouakou-Zebouah | M | - |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | 5 Jahre |
| Miriam Holstein | M | - | 2 Jahre | |
| Heba Nowyhed | F | - |
VV Manager LLC
VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | 5 Jahre |
| Jyoti Mehra | F | 48 | 7 Jahre | |
| Vineeta Agarwala | M | - |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | - |
| Yasmin Fahimi | F | 56 | 2 Jahre | |
| Linda Higgins | M | 62 | 14 Jahre | |
| William Anderson | M | 57 | 1 Jahre | |
| Francesco Grioli | M | 52 | 2 Jahre | |
| Stefan Oelrich | M | 55 | 6 Jahre | |
| Peter J. Uggowitzer | M | 73 |
Swiss Federal Institute of Technology
| 43 Jahre |
| Robert Cook | M | 65 | 12 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Gregg Alton | M | 58 | 20 Jahre | |
| Werner Wenning | M | 77 | 54 Jahre | |
| Brett Pletcher | M | 56 | 17 Jahre | |
| Werner Baumann | M | 60 | 35 Jahre | |
| John Martin | M | 72 | 29 Jahre | |
| Hartmut Klusik | M | 67 | 3 Jahre | |
| Barbara Kosacz | F | 66 | 4 Jahre | |
| Martin Zanon | M | 68 |
University of Innsbruck
| 6 Jahre |
| Mark Perry | M | 68 | 10 Jahre | |
| Marianne de Backer | M | 55 | 4 Jahre | |
| Marni Kottle | F | - | 11 Jahre | |
| Jakob Loven | M | 46 | - | |
| Ernesto Schümperli | M | 68 |
Swiss Federal Institute of Technology
| 6 Jahre |
| Dieter Weinand | M | 63 | 5 Jahre | |
| Jerry Cacia | M | 57 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 28 Jahre |
| Monica Tellado | F | 51 | 9 Jahre | |
| Otmar D. Wiestler | M | 67 | 10 Jahre | |
| Rebecka Belldegrun | M | - | - | |
| Laurent Vulliet | M | 66 |
Swiss Federal Institute of Technology
| 8 Jahre |
| John M. Whiting | M | 69 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 20 Jahre |
| Petra Kronen | F | 59 | 37 Jahre | |
| Johannes M. Dietsch | M | 62 | 16 Jahre | |
| John Francis Cogan | M | 76 | - | |
| Richard Whitley | M | 78 | 13 Jahre | |
| Kevin Lofton | M | 69 | 15 Jahre | |
| Steven Shak | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 Jahre |
| Nicholas G. Moore | M | 82 | - | |
| Lukas Braunschweiler | M | 68 |
Swiss Federal Institute of Technology
| 4 Jahre |
| Étienne Francois Davignon | M | 91 | - | |
| Carla A. Hills | F | 90 | - | |
| Victor Waldemar Balli | M | 67 |
Swiss Federal Institute of Technology
| 5 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 69 | 69,00% |
| Deutschland | 31 | 31,00% |
| Österreich | 1 | 1,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Norbert W. Bischofberger
- Persönliches Netzwerk
